463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapy

• Tong Hu,
• Milan Chheda,
• Albert Kim,
• Ashwani Kesarwani,
• Amanda De Andrade Costa,
• Jeremy N Rich,
• Pei-Yong Shi,
• Michael S Diamond

Affiliations

Tong Hu

1Washington University School of Medicine, Saint Louis, MO, USA

Milan Chheda

1Washington University School of Medicine, Saint Louis, MO, USA

Albert Kim

1Washington University in Saint Louis, St. Louis, MO, USA

Ashwani Kesarwani

1Washington University in St. Louis, St. Louis, MO, USA

Amanda De Andrade Costa

1Washington University in St. Louis, St. Louis, MO, USA

Jeremy N Rich

2University of Pittsburgh, Pittsburgh, PA, USA

Pei-Yong Shi

3University of Texas, Texas, TX, USA

Michael S Diamond

1Washington University in St. Louis, St. Louis, MO, USA